Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Rezivertinib

Catalog No.
BA6337
Add to Compare
Rezivertinib (BPI-7711) is an orally effective, highly selective and irreversible third-generation tyrosine kinase inhibitor (TKI).
Grouped product items
SizePriceStock Qty
1mL(10 mM in DMSO)
$297.00
Ship with 10-15 days
1mg
$122.00
Ship with 10-15 days
5mg
$270.00
Ship with 10-15 days
10mg
$432.00
Ship with 10-15 days
25mg
$855.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Rezivertinib (BPI-7711) is an orally effective, highly selective and irreversible third-generation tyrosine kinase inhibitor (TKI).Rezivertinib is highly potent against common activating and resistant T790M mutations.Rezivertinib exhibits excellent transmigration through the central nervous system (CNS) and has antitumor Activity.

Chemical Properties

Physical AppearanceA solid
Storage-20°C
M.Wt486.57
Cas No.1835667-12-3
FormulaC27H30N6O3
SynonymsBPI-7711
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.